CureSee's Cutting-Edge Technology for Eye Treatment

CureSee is a startup founded by Puneet and Jatin, childhood friends who both have a passion for optometry, and Amit Sahni, who they met through an industrial connection. The company was established in 2017, and they have since become the world's number one eye check-up software brand.

The company was founded to solve the problem of lazy eye or Amblyopia, which affects 30 crore people worldwide. Lazy eye is a condition where the eye doesn't develop proper vision even after wearing spectacles, and the treatment is to wear an eye patch. To address this issue, CureSee has developed an artificial intelligence-based vision therapy website that focuses on three problems of the human eye: Amblyopia, squint eye, and convergence insufficiency.

AIM OF THE STARTUP

The aim of CureSee, the startup founded by Puneet, Jatin, and Amit Sahni, is to solve the problem of lazy eye or Amblyopia, which affects millions of people worldwide. The traditional treatment for this condition is to wear an eye patch, which can be uncomfortable and inconvenient for patients.

To address this issue, CureSee has developed an artificial intelligence-based vision therapy website that focuses on three problems of the human eye: Amblyopia, squint eye, and convergence insufficiency. The website offers a free eye screening for users, which is the first step towards getting started with their service. The website then suggests vision therapy exercises, and users can expect to see positive results in just 1-2 months of usage.

CureSee's aim is to provide an effective and convenient solution for people suffering from lazy eye or other eye conditions. They are using innovative technology to make eye therapy more accessible and comfortable for patients. By utilizing AI technology and anaglyph glasses to play games and draw results, they are creating a unique and effective approach to vision therapy.

Moreover, CureSee's ultimate goal is to improve the quality of life for people with eye conditions by providing affordable, accessible, and effective treatment. Their efforts have already been recognized by the government of India, and they are continuously working to improve their technology and services. The startup's commitment to research and development is evident from the research papers they have published and the ones that are awaiting approval from AIIMS.

TARGET MARKET

CureSee targets people suffering from various eye conditions such as Amblyopia, Squint eye, and Convergence Insufficiency. These conditions affect millions of people worldwide and require specialized treatment and care to improve vision.

CureSee's target market primarily includes individuals of all ages who suffer from the above eye conditions. However, the startup also caters to parents of children with these eye conditions, who are looking for an effective and convenient solution to improve their child's vision. The startup's vision therapy exercises are designed to be completed at home, making them more convenient and comfortable for patients.

In addition, CureSee's target market includes people who are looking for an affordable and accessible solution for their eye conditions. Traditional treatments for eye conditions can be costly and require multiple visits to a specialist. CureSee's subscription-based service provides an affordable option for patients to receive personalized vision therapy exercises that they can complete from the comfort of their own homes.

CureSee also targets healthcare providers such as optometrists and ophthalmologists, who may recommend the startup's services to their patients. By collaborating with healthcare providers, CureSee aims to expand its reach and impact more people who may benefit from their vision therapy exercises

SALES AND REVENUE

CureSee generates revenue as a SaaS (Software as a Service) company by offering a subscription-based service to hospitals. The subscription fee for their services ranges from INR 12,000 to INR 18,000 for a three-month period. The startup's monthly revenue is approximately INR 2.64 lakhs.

FUNDING IN SHARK TANKS INDIA

The owner of the company asked for 40 lakhs rupees in exchange for 5% equity in the company.

The sharks showed interest in investing in the company and made several offers and counteroffers. Namita made an offer of 40 lakhs rupees for 10% equity in the company, while Peyush offered 1 crore rupees for 25% equity or 40 lakhs rupees for 10% equity.

Namita then countered with an offer of 40 lakhs rupees for 7.5% equity with increased valuation, and the pitcher also countered with an offer of 40 lakhs for 7.5% equity to Peyush. Namita made another counteroffer of 40 lakhs rupees in exchange for 5% equity.

Ultimately, CureSee's final deal was struck with Peyush, who offered 50 lakhs rupees for 10% equity in the company.